Cannabidiol (CBD) is one of the phytocannabinoids found in the cannabis plant. According to multiple scientific and medical sources, CBD has important medical benefits. Since 2013, the National Institutes of Health (PubMed) service has included over 1,100 studies on CBD in its index.
The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder. Alembic Pharmaceuticals Ltd., Hetero Labs Ltd., Teva Pharmaceuticals and Torrent Pharmaceuticals Ltd. have received FDA approval to market generic aripiprazole in multiple strengths and dosage forms.
When did the U.S. Food and Drug Administration (FDA) approve the medication? Abilify was first approved by the FDA to treat schizophrenia in 2002. Is there a generic version of Abilify? Yes, the generic name for the medication is aripiprazole and is available for purchase in the United States. Are there any major differences between Abilify and other antipsychotics used to treat Abilify? Abilify belongs to the class of medications known as atypical antipsychotics or second generation psychotics.